Group One Trading, L.P. 89bio, Inc. Transaction History
Group One Trading, L.P.
- $3.01 Billion
- Q2 2024
A detailed history of Group One Trading, L.P. transactions in 89bio, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 41,232 shares of ETNB stock, worth $344,699. This represents 0.01% of its overall portfolio holdings.
Number of Shares
41,232
Previous 11,963
244.66%
Holding current value
$344,699
Previous $139,000
137.41%
% of portfolio
0.01%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding ETNB
# of Institutions
157Shares Held
107MCall Options Held
65KPut Options Held
1.2M-
Ra Capital Management, L.P. Boston, MA14.2MShares$119 Million1.71% of portfolio
-
Janus Henderson Group PLC London, X013.3MShares$111 Million0.06% of portfolio
-
Suvretta Capital Management, LLC New York, NY8.03MShares$67.1 Million2.69% of portfolio
-
Bvf Inc San Francisco, CA7.57MShares$63.3 Million1.85% of portfolio
-
Rtw Investments, LP New York, NY7.38MShares$61.7 Million0.99% of portfolio
About 89bio, Inc.
- Ticker ETNB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,484,500
- Market Cap $389M
- Description
- 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...